Need Help?

NanoString Cancer

RCC files of 17 Cartridges from metastatic melanoma

Request Access

Terms and conditions, as established by the Melanoma Institute Australia, that users wishing to access this dataset must agree to meet.

Data-Use Agreement Please read the following statements and if you accept the terms of the agreement, return a signed copy to the Melanoma Institute Australia (MIA) Research Committee Secretary at research@melanoma.org.au Purpose: This agreement has been established to outline your requirements under Australian Law (Privacy Act) and to comply with HREC Approvals, Research Code of Conduct and MIA Research Policy. It is of utmost importance to protect the identities of cancer patients. Every effort has been made to exclude identifying information on individual patients. Certain demographic information - such as sex, race, etc. - has been included for research purposes. All research results must be presented or published in a manner that ensures that no individual can be identified. In order for the MIA to provide access to this Research Data, it is necessary that you agree to the following provisions. 1 The research data will be stored safely and securely. The lead researcher of the project at the collaborating institution is responsible for ensuring the Research Data is stored safely and securely. 2 I will not use - or permit others to use - the data in any way other than for statistical reporting and analysis for the approved research purposes. I must notify the Melanoma Institute Australia Research Committee (MIARC) Secretary if I discover that there has been any other use of the data. 3 I will not present or publish data in which an individual patient can be identified. 4 I will not attempt either to perform data linkage - or permit others to link - the data with individually identified records in another database without a Specific Human Ethics approval for the linkage. 5 I will not attempt to learn the identity of any patient whose disease data is contained in the supplied file(s). 6 If I inadvertently discover the identity of any patient, then (a) I will make no use of this knowledge, (b) I will notify the MIARC Secretary of the incident, and (c) I will inform no one else of the discovered identity. 7 I will not release - or permit others to release - the data - in full or in part - to any other person except with the written approval of the MIA Research Committee. In particular, all members of a research team who have access to the data must sign to this data-use agreement. 8 I will use appropriate safeguards to prevent use or disclosure of the information other than as provided for by this data-use agreement. If accessing the data from a centralized location on a time sharing computer system or any shared network drives, I will not share my logon name or password with any other individuals. I will also not allow any other individuals to use my computer account after I have logged on with my logon name and password. 9 If I leave the organisation and would like to continue to work on the research project, I will contact research@melanoma.org.au to find out if this is possible. I will nominate how long I need access for and my supervisor will need to approve this. 10 Any publications which include the Research data will acknowledge the source of data as the Melanoma Research Database at Melanoma Institute Australia. All publications should acknowledge the University of Sydney, Melanoma Institute Australia and the Sydney Local Health District as owners of the database. Suggested wording - We would like to thank the University of Sydney, Melanoma Institute Australia and the Sydney Local Health District for the data they have provided for this research. 11 At the conclusion of the project I will ensure that after having met any archiving requirements the data is destroyed. 12 My signature indicates that I agree to comply with the above stated provisions. AGREEMENT TO TERMS OF RELEASE OF CONFIDENTIAL MELANOMA INSTITUTE RESEARCH DATA I, ________________[full name], hereby agree to the terms and conditions relating to the release of the confidential Melanoma Institute Research data for use in: Project Title: _____________________________________________________________________ Signature _____________________________________________________________________ Date

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006977 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00007916515 RCC 27.7 kB
EGAF00007916516 RCC 27.6 kB
EGAF00007916517 RCC 27.1 kB
EGAF00007916518 RCC 27.9 kB
EGAF00007916519 RCC 27.2 kB
EGAF00007916520 RCC 27.6 kB
EGAF00007916521 RCC 27.4 kB
EGAF00007916522 RCC 26.7 kB
EGAF00007916523 RCC 27.8 kB
EGAF00007916524 RCC 26.8 kB
EGAF00007916525 RCC 27.8 kB
EGAF00007916526 RCC 27.6 kB
EGAF00007916527 RCC 27.6 kB
EGAF00007916528 RCC 27.6 kB
EGAF00007916529 RCC 27.7 kB
EGAF00007916530 RCC 26.3 kB
EGAF00007916532 RCC 27.4 kB
EGAF00007916533 RCC 27.7 kB
EGAF00007916534 RCC 27.5 kB
EGAF00007916535 RCC 27.4 kB
EGAF00007916536 RCC 27.9 kB
EGAF00007916537 RCC 27.3 kB
EGAF00007916539 RCC 27.7 kB
EGAF00007916540 RCC 27.5 kB
EGAF00007916541 RCC 27.6 kB
EGAF00007916542 RCC 27.7 kB
EGAF00007916543 RCC 27.8 kB
EGAF00007916544 RCC 27.8 kB
EGAF00007916545 RCC 27.5 kB
EGAF00007916546 RCC 27.5 kB
EGAF00007916547 RCC 26.8 kB
EGAF00007916548 RCC 27.2 kB
EGAF00007916549 RCC 27.2 kB
EGAF00007916550 RCC 27.2 kB
EGAF00007916551 RCC 27.6 kB
EGAF00007916552 RCC 28.0 kB
EGAF00007916553 RCC 27.7 kB
EGAF00007916554 RCC 27.6 kB
EGAF00007916555 RCC 27.4 kB
EGAF00007916556 RCC 27.8 kB
EGAF00007916557 RCC 26.8 kB
EGAF00007916558 RCC 27.7 kB
EGAF00007916559 RCC 27.7 kB
EGAF00007916561 RCC 27.7 kB
EGAF00007916562 RCC 27.5 kB
EGAF00007916564 RCC 27.5 kB
EGAF00007916565 RCC 27.2 kB
EGAF00007916566 RCC 27.8 kB
EGAF00007916567 RCC 27.7 kB
EGAF00007916568 RCC 27.5 kB
EGAF00007916569 RCC 27.5 kB
EGAF00007916570 RCC 27.7 kB
EGAF00007916571 RCC 27.4 kB
EGAF00007916572 RCC 27.7 kB
EGAF00007916574 RCC 27.1 kB
EGAF00007916576 RCC 27.5 kB
EGAF00007916577 RCC 27.0 kB
EGAF00007916578 RCC 27.7 kB
EGAF00007916579 RCC 27.6 kB
EGAF00007916580 RCC 27.6 kB
EGAF00007916581 RCC 27.6 kB
EGAF00007916583 RCC 27.5 kB
EGAF00007916584 RCC 27.8 kB
EGAF00007916585 RCC 26.7 kB
EGAF00007916586 RCC 27.7 kB
EGAF00007916588 RCC 27.5 kB
EGAF00007916589 RCC 27.5 kB
EGAF00007916590 RCC 27.9 kB
EGAF00007916591 RCC 26.8 kB
EGAF00007916592 RCC 27.7 kB
EGAF00007916593 RCC 27.3 kB
EGAF00007916594 RCC 27.8 kB
EGAF00007916595 RCC 27.6 kB
EGAF00007916596 RCC 27.6 kB
EGAF00007916597 RCC 26.5 kB
EGAF00007916598 RCC 27.7 kB
EGAF00007916599 RCC 27.9 kB
EGAF00007916601 RCC 27.4 kB
EGAF00007916602 RCC 27.6 kB
EGAF00007916603 RCC 27.7 kB
EGAF00007916604 RCC 27.3 kB
EGAF00007916605 RCC 27.9 kB
EGAF00007916606 RCC 27.3 kB
EGAF00007916607 RCC 27.6 kB
EGAF00007916609 RCC 27.8 kB
EGAF00007916610 RCC 27.6 kB
EGAF00007916612 RCC 27.0 kB
EGAF00007916613 RCC 27.9 kB
EGAF00007916614 RCC 27.5 kB
EGAF00007916615 RCC 27.8 kB
EGAF00007916616 RCC 27.5 kB
EGAF00007916617 RCC 27.6 kB
EGAF00007916618 RCC 27.5 kB
EGAF00007916619 RCC 27.3 kB
EGAF00007916620 RCC 27.7 kB
EGAF00007916621 RCC 27.8 kB
EGAF00007916622 RCC 27.5 kB
EGAF00007916624 RCC 27.2 kB
EGAF00007916625 RCC 27.4 kB
EGAF00007916626 RCC 27.7 kB
EGAF00007916628 RCC 27.7 kB
EGAF00007916629 RCC 27.6 kB
EGAF00007916631 RCC 26.7 kB
EGAF00007916632 RCC 27.4 kB
EGAF00007916633 RCC 27.3 kB
EGAF00007916634 RCC 26.8 kB
EGAF00007916635 RCC 27.6 kB
EGAF00007916636 RCC 27.9 kB
EGAF00007916637 RCC 27.3 kB
EGAF00007916638 RCC 27.6 kB
EGAF00007916639 RCC 27.6 kB
EGAF00007916640 RCC 27.8 kB
EGAF00007916641 RCC 27.7 kB
EGAF00007916642 RCC 27.8 kB
EGAF00007916643 RCC 27.2 kB
EGAF00007916644 RCC 27.6 kB
EGAF00007916645 RCC 27.4 kB
EGAF00007916646 RCC 27.7 kB
EGAF00007916647 RCC 27.1 kB
EGAF00007916648 RCC 26.7 kB
EGAF00007916649 RCC 26.6 kB
EGAF00007916650 RCC 27.3 kB
EGAF00007916651 RCC 27.5 kB
EGAF00007916652 RCC 27.8 kB
EGAF00007916653 RCC 27.7 kB
EGAF00007916654 RCC 27.3 kB
EGAF00007916655 RCC 26.4 kB
EGAF00007916656 RCC 26.9 kB
EGAF00007916658 RCC 26.7 kB
EGAF00007916659 RCC 27.6 kB
EGAF00007916660 RCC 27.8 kB
EGAF00007916661 RCC 27.3 kB
EGAF00007916662 RCC 27.9 kB
EGAF00007916663 RCC 27.6 kB
EGAF00007916664 RCC 27.0 kB
EGAF00007916665 RCC 27.3 kB
EGAF00007916666 RCC 27.6 kB
EGAF00007916667 RCC 27.4 kB
EGAF00007916668 RCC 27.6 kB
EGAF00007916669 RCC 26.5 kB
EGAF00007916670 RCC 27.0 kB
EGAF00007916671 RCC 27.7 kB
EGAF00007916672 RCC 27.5 kB
EGAF00007916673 RCC 27.5 kB
EGAF00007916674 RCC 27.9 kB
EGAF00007916675 RCC 27.3 kB
EGAF00007916676 RCC 27.3 kB
EGAF00007916677 RCC 27.5 kB
EGAF00007916678 RCC 27.5 kB
EGAF00007916679 RCC 27.5 kB
EGAF00007916680 RCC 27.8 kB
EGAF00007916681 RCC 26.7 kB
EGAF00007916682 RCC 27.6 kB
EGAF00007916683 RCC 27.4 kB
EGAF00007916684 RCC 27.5 kB
EGAF00007916685 RCC 27.2 kB
EGAF00007916686 RCC 27.7 kB
EGAF00007916687 RCC 27.7 kB
EGAF00007916688 RCC 27.7 kB
EGAF00007916689 RCC 27.2 kB
EGAF00007916690 RCC 26.6 kB
EGAF00007916691 RCC 28.1 kB
EGAF00007916692 RCC 27.7 kB
EGAF00007916693 RCC 27.7 kB
EGAF00007916694 RCC 27.3 kB
EGAF00007916696 RCC 27.1 kB
EGAF00007916697 RCC 27.6 kB
EGAF00007916698 RCC 27.5 kB
EGAF00007916699 RCC 27.6 kB
EGAF00007916700 RCC 27.1 kB
EGAF00007916702 RCC 27.7 kB
EGAF00007916703 RCC 27.8 kB
EGAF00007916704 RCC 27.7 kB
EGAF00007916705 RCC 27.8 kB
EGAF00007916706 RCC 27.9 kB
EGAF00007916707 RCC 27.1 kB
EGAF00007916708 RCC 27.5 kB
EGAF00007916709 RCC 27.7 kB
EGAF00007916710 RCC 27.6 kB
EGAF00007916711 RCC 27.9 kB
EGAF00007916712 RCC 27.4 kB
EGAF00007916713 RCC 27.9 kB
EGAF00007916714 RCC 27.4 kB
EGAF00007916715 RCC 27.0 kB
EGAF00007916716 RCC 27.5 kB
185 Files (5.1 MB)